+1 347 708 0418
The Gene Editing Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gene Editing Technologies size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gene Editing Technologies market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gene Editing Technologies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Double Strand Break Repair
Engineered Nucleases
Clustered Regularly Interspaced Short Palindromic Repeats
Market segment by Application, can be divided into
Gene Therapy
Eradicating Diseases
Market segment by players, this report covers
Thermo Fisher Scientific
Merck
Sangamo Therapeutics
Lonza
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
Agilent Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Gene Editing Technologies
1.2 Classification of Gene Editing Technologies by Type
1.2.1 Overview: Global Gene Editing Technologies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gene Editing Technologies Revenue Market Share by Type in 2020
1.2.3 Double Strand Break Repair
1.2.4 Engineered Nucleases
1.2.5 Clustered Regularly Interspaced Short Palindromic Repeats
1.3 Global Gene Editing Technologies Market by Application
1.3.1 Overview: Global Gene Editing Technologies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Gene Therapy
1.3.3 Eradicating Diseases
1.4 Global Gene Editing Technologies Market Size & Forecast
1.5 Global Gene Editing Technologies Market Size and Forecast by Region
1.5.1 Global Gene Editing Technologies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gene Editing Technologies Market Size by Region, (2016-2021)
1.5.3 North America Gene Editing Technologies Market Size and Prospect (2016-2026)
1.5.4 Europe Gene Editing Technologies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gene Editing Technologies Market Size and Prospect (2016-2026)
1.5.6 South America Gene Editing Technologies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gene Editing Technologies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Editing Technologies Market Drivers
1.6.2 Gene Editing Technologies Market Restraints
1.6.3 Gene Editing Technologies Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Gene Editing Technologies Product and Solutions
2.1.4 Thermo Fisher Scientific Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Gene Editing Technologies Product and Solutions
2.2.4 Merck Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Sangamo Therapeutics
2.3.1 Sangamo Therapeutics Details
2.3.2 Sangamo Therapeutics Major Business
2.3.3 Sangamo Therapeutics Gene Editing Technologies Product and Solutions
2.3.4 Sangamo Therapeutics Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sangamo Therapeutics Recent Developments and Future Plans
2.4 Lonza
2.4.1 Lonza Details
2.4.2 Lonza Major Business
2.4.3 Lonza Gene Editing Technologies Product and Solutions
2.4.4 Lonza Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Lonza Recent Developments and Future Plans
2.5 Transposagen Biopharmaceuticals
2.5.1 Transposagen Biopharmaceuticals Details
2.5.2 Transposagen Biopharmaceuticals Major Business
2.5.3 Transposagen Biopharmaceuticals Gene Editing Technologies Product and Solutions
2.5.4 Transposagen Biopharmaceuticals Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.6 Editas Medicine
2.6.1 Editas Medicine Details
2.6.2 Editas Medicine Major Business
2.6.3 Editas Medicine Gene Editing Technologies Product and Solutions
2.6.4 Editas Medicine Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Editas Medicine Recent Developments and Future Plans
2.7 CRISPR Therapeutics
2.7.1 CRISPR Therapeutics Details
2.7.2 CRISPR Therapeutics Major Business
2.7.3 CRISPR Therapeutics Gene Editing Technologies Product and Solutions
2.7.4 CRISPR Therapeutics Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 CRISPR Therapeutics Recent Developments and Future Plans
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies Gene Editing Technologies Product and Solutions
2.8.4 Agilent Technologies Gene Editing Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Agilent Technologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Editing Technologies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Editing Technologies Players Market Share
3.2.2 Top 10 Gene Editing Technologies Players Market Share
3.2.3 Market Competition Trend
3.3 Gene Editing Technologies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gene Editing Technologies Revenue and Market Share by Type (2016-2021)
4.2 Global Gene Editing Technologies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gene Editing Technologies Revenue Market Share by Application (2016-2021)
5.2 Gene Editing Technologies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gene Editing Technologies Revenue by Type (2016-2026)
6.2 North America Gene Editing Technologies Revenue by Application (2016-2026)
6.3 North America Gene Editing Technologies Market Size by Country
6.3.1 North America Gene Editing Technologies Revenue by Country (2016-2026)
6.3.2 United States Gene Editing Technologies Market Size and Forecast (2016-2026)
6.3.3 Canada Gene Editing Technologies Market Size and Forecast (2016-2026)
6.3.4 Mexico Gene Editing Technologies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Editing Technologies Revenue by Type (2016-2026)
7.2 Europe Gene Editing Technologies Revenue by Application (2016-2026)
7.3 Europe Gene Editing Technologies Market Size by Country
7.3.1 Europe Gene Editing Technologies Revenue by Country (2016-2026)
7.3.2 Germany Gene Editing Technologies Market Size and Forecast (2016-2026)
7.3.3 France Gene Editing Technologies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gene Editing Technologies Market Size and Forecast (2016-2026)
7.3.5 Russia Gene Editing Technologies Market Size and Forecast (2016-2026)
7.3.6 Italy Gene Editing Technologies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Editing Technologies Revenue by Type (2016-2026)
8.2 Asia-Pacific Gene Editing Technologies Revenue by Application (2016-2026)
8.3 Asia-Pacific Gene Editing Technologies Market Size by Region
8.3.1 Asia-Pacific Gene Editing Technologies Revenue by Region (2016-2026)
8.3.2 China Gene Editing Technologies Market Size and Forecast (2016-2026)
8.3.3 Japan Gene Editing Technologies Market Size and Forecast (2016-2026)
8.3.4 South Korea Gene Editing Technologies Market Size and Forecast (2016-2026)
8.3.5 India Gene Editing Technologies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gene Editing Technologies Market Size and Forecast (2016-2026)
8.3.7 Australia Gene Editing Technologies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gene Editing Technologies Revenue by Type (2016-2026)
9.2 South America Gene Editing Technologies Revenue by Application (2016-2026)
9.3 South America Gene Editing Technologies Market Size by Country
9.3.1 South America Gene Editing Technologies Revenue by Country (2016-2026)
9.3.2 Brazil Gene Editing Technologies Market Size and Forecast (2016-2026)
9.3.3 Argentina Gene Editing Technologies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Editing Technologies Revenue by Type (2016-2026)
10.2 Middle East & Africa Gene Editing Technologies Revenue by Application (2016-2026)
10.3 Middle East & Africa Gene Editing Technologies Market Size by Country
10.3.1 Middle East & Africa Gene Editing Technologies Revenue by Country (2016-2026)
10.3.2 Turkey Gene Editing Technologies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gene Editing Technologies Market Size and Forecast (2016-2026)
10.3.4 UAE Gene Editing Technologies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Gene Editing Technologies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gene Editing Technologies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gene Editing Technologies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gene Editing Technologies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gene Editing Technologies Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Gene Editing Technologies Product and Solutions
Table 9. Thermo Fisher Scientific Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Gene Editing Technologies Product and Solutions
Table 13. Merck Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sangamo Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Sangamo Therapeutics Major Business
Table 16. Sangamo Therapeutics Gene Editing Technologies Product and Solutions
Table 17. Sangamo Therapeutics Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Lonza Corporate Information, Head Office, and Major Competitors
Table 19. Lonza Major Business
Table 20. Lonza Gene Editing Technologies Product and Solutions
Table 21. Lonza Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Transposagen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Transposagen Biopharmaceuticals Major Business
Table 24. Transposagen Biopharmaceuticals Gene Editing Technologies Product and Solutions
Table 25. Transposagen Biopharmaceuticals Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 27. Editas Medicine Major Business
Table 28. Editas Medicine Gene Editing Technologies Product and Solutions
Table 29. Editas Medicine Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. CRISPR Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. CRISPR Therapeutics Major Business
Table 32. CRISPR Therapeutics Gene Editing Technologies Product and Solutions
Table 33. CRISPR Therapeutics Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 35. Agilent Technologies Major Business
Table 36. Agilent Technologies Gene Editing Technologies Product and Solutions
Table 37. Agilent Technologies Gene Editing Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Gene Editing Technologies Revenue (USD Million) by Players (2019-2021)
Table 39. Global Gene Editing Technologies Revenue Share by Players (2019-2021)
Table 40. Breakdown of Gene Editing Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Gene Editing Technologies Players Head Office, Products and Services Provided
Table 42. Gene Editing Technologies Mergers & Acquisitions in the Past Five Years
Table 43. Gene Editing Technologies New Entrants and Expansion Plans
Table 44. Global Gene Editing Technologies Revenue (USD Million) by Type (2016-2021)
Table 45. Global Gene Editing Technologies Revenue Share by Type (2016-2021)
Table 46. Global Gene Editing Technologies Revenue Forecast by Type (2021-2026)
Table 47. Global Gene Editing Technologies Revenue by Application (2016-2021)
Table 48. Global Gene Editing Technologies Revenue Forecast by Application (2021-2026)
Table 49. North America Gene Editing Technologies Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Gene Editing Technologies Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Gene Editing Technologies Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Gene Editing Technologies Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Gene Editing Technologies Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Gene Editing Technologies Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Gene Editing Technologies Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Gene Editing Technologies Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Gene Editing Technologies Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Gene Editing Technologies Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Gene Editing Technologies Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Gene Editing Technologies Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Gene Editing Technologies Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Gene Editing Technologies Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Gene Editing Technologies Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Gene Editing Technologies Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Gene Editing Technologies Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Gene Editing Technologies Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Gene Editing Technologies Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Gene Editing Technologies Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Gene Editing Technologies Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Gene Editing Technologies Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Gene Editing Technologies Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Gene Editing Technologies Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Gene Editing Technologies Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Gene Editing Technologies Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Gene Editing Technologies Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Gene Editing Technologies Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Gene Editing Technologies Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Gene Editing Technologies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gene Editing Technologies Picture
Figure 2. Global Gene Editing Technologies Revenue Market Share by Type in 2020
Figure 3. Double Strand Break Repair
Figure 4. Engineered Nucleases
Figure 5. Clustered Regularly Interspaced Short Palindromic Repeats
Figure 6. Gene Editing Technologies Revenue Market Share by Application in 2020
Figure 7. Gene Therapy Picture
Figure 8. Eradicating Diseases Picture
Figure 9. Global Gene Editing Technologies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Gene Editing Technologies Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Gene Editing Technologies Revenue Market Share by Region (2016-2026)
Figure 12. Global Gene Editing Technologies Revenue Market Share by Region in 2020
Figure 13. North America Gene Editing Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Gene Editing Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Gene Editing Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Gene Editing Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Gene Editing Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Gene Editing Technologies Market Drivers
Figure 19. Gene Editing Technologies Market Restraints
Figure 20. Gene Editing Technologies Market Trends
Figure 21. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Sangamo Therapeutics Recent Developments and Future Plans
Figure 24. Lonza Recent Developments and Future Plans
Figure 25. Transposagen Biopharmaceuticals Recent Developments and Future Plans
Figure 26. Editas Medicine Recent Developments and Future Plans
Figure 27. CRISPR Therapeutics Recent Developments and Future Plans
Figure 28. Agilent Technologies Recent Developments and Future Plans
Figure 29. Global Gene Editing Technologies Revenue Share by Players in 2020
Figure 30. Gene Editing Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Gene Editing Technologies Revenue Market Share in 2020
Figure 32. Global Top 10 Players Gene Editing Technologies Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Gene Editing Technologies Revenue Share by Type in 2020
Figure 35. Global Gene Editing Technologies Market Share Forecast by Type (2021-2026)
Figure 36. Global Gene Editing Technologies Revenue Share by Application in 2020
Figure 37. Global Gene Editing Technologies Market Share Forecast by Application (2021-2026)
Figure 38. North America Gene Editing Technologies Sales Market Share by Type (2016-2026)
Figure 39. North America Gene Editing Technologies Sales Market Share by Application (2016-2026)
Figure 40. North America Gene Editing Technologies Revenue Market Share by Country (2016-2026)
Figure 41. United States Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Gene Editing Technologies Sales Market Share by Type (2016-2026)
Figure 45. Europe Gene Editing Technologies Sales Market Share by Application (2016-2026)
Figure 46. Europe Gene Editing Technologies Revenue Market Share by Country (2016-2026)
Figure 47. Germany Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Gene Editing Technologies Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Gene Editing Technologies Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Gene Editing Technologies Revenue Market Share by Region (2016-2026)
Figure 55. China Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Gene Editing Technologies Sales Market Share by Type (2016-2026)
Figure 62. South America Gene Editing Technologies Sales Market Share by Application (2016-2026)
Figure 63. South America Gene Editing Technologies Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Gene Editing Technologies Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Gene Editing Technologies Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Gene Editing Technologies Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Gene Editing Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
Buy
